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MOLECULAR	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  EGR-­‐1	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BACKGROUND	  
Demographics	  of	  prostate	  cancer:	  
•  80%	  men	  before	  the	  age	  of	  80	  are	  diagnosed	  
•  233,000	  men	  are	  diagnosed	  each	  year	  	  
•  30,000	  men	  die	  each	  year	  (one	  death	  every	  16	  minutes)	  
DEFINITION	  of	  ﬁeld	  canceriza?on:	  Molecular	  altera?ons	  (gene?c/biochemical)	  in	  
structurally	   intact	   cells	   residing	   in	   histologically	   normal	   ?ssues	   adjacent	   to	  
tumors.	   This	   may	   represent	   a	   state	   of	   pre-­‐malignancy	   before	   histologically	  
change.	  
SIGNIFICANCE	  of	  ﬁeld	  canceriza?on:	  Increase	  of	  the	  clinically	  informa?ve	  ?ssue	  
area	   in	   prostate	   ?ssues,	   for	   example	   for	   the	   reduc?on	   of	   false	   nega?ve	  
detec?on	  rate	  (diagnosis)	  in	  biopsies.	  
We	  have	  previously	   shown	  ﬁeld	  canceriza?on	   in	  histologically	  normal	  ?ssues	  1	  
cm	  adjacent	  to	  prostate	  tumor	  margins:	  
•  Telomere	  aMri:on	  (genomic	  instability).	  
•  Altered	   expression	   of	   the	   transcrip:on	   factor	   early	   growth	   response	   1	  
protein	   (EGR-­‐1),	   the	   secreted	   pro-­‐survival	   factors	   macrophage	   inhibitory	  
cytokine	  1	  (MIC-­‐1)	  and	  platelet	  derived	  growth	  factor	  A	  (PDGF-­‐A),	  and	  the	  
lipogenic	  enzyme	  faMy	  acid	  synthase	  (FAS).	  
Tissue	  resec)on	  and	  H&E	  histology	  of	  tumor	  
(T)	   and	   histologically	   normal	   adjacent	  
prostate	   )ssue	   removed	   at	   1	   cm	   from	   the	  
tumor	  margin.	  
Telomere	  length	  (color	  coded)	  in	  whole	  
mount	   prostates.	   Telomere	   length	  
increases	  with	  increasing	  distance	  (A-­‐F)	  
from	  a	  tumor.	  	  
Tumor	  
Telomere	  length	  
	  	  -­‐	  Short	  =	  red	  
	  	  -­‐	  Long	  =	  yellow	  
EGR-­‐1	   expression	   determined	   by	  
immunoﬂuorescence	   in	   tumor,	   tumor	  
adjacent	   histologically	   normal	   (ﬁeld	  
cancerized),	   and	   disease-­‐free	   prostate	  
)ssues.	  
HYPOTHESIS	  
The	  molecular	   mechanisms	   and	   pathways	   leading	   to	   the	   molecular	   altera?ons	  
characteris?c	  for	  prostate	  ﬁeld	  canceriza?on	  remain	  unknown.	  WE	  HYPOTHESIZE	  
THAT:	  
Micro-­‐environmental	   factors	   induce	   ﬁeld	   canceriza:on	   through	   genomic	  
instability	   (telomere	   aMri:on),	   p53	   muta:ons,	   induc:on	   of	   EGR-­‐1	   and	  
expression	  of	  MIC-­‐1,	  PDGF-­‐A,	  and	  FAS.	  
OBJECTIVE	  
To	   test	   steps	   of	   the	   hypothesized	   model	   for	   molecular	   prostate	   ﬁeld	  
canceriza?on.	  In	  par?cular,	  we	  addressed	  herein	  the	  following	  ques?ons:	  
•  Does	  EGR-­‐1	  regulate	  the	  expression	  of	  MIC-­‐1,	  PDGF-­‐A,	  and	  FAS?	  
	  RATIONALE:	  EGR-­‐1	  is	  a	  key	  transcrip:on	  factor.	  
•  Does	   N,N'-­‐bis	   [2-­‐(1-­‐piperidino)ethyl]-­‐3,4,9,10-­‐tetracarboxylic	   diimide	  
(PIPER)	  induce	  EGR-­‐1	  expression?	  
	   RATIONALE:	   PIPER	   inhibits	   the	   enzyme	   telomerase	   that	   	   maintains	  
telomere	  length.	  	  
METHODS	  
Computa:onal	  EGR-­‐1	   transcrip:on	   factor	  binding	   site	  analysis	  was	  performed	  using	   the	  
Tfsitescan	  sokware	  (hlp://www.iki.org/cgi-­‐bin/iki/Tfsitescan.pl)	  and	  genomic	  sequences	  
for	   EGR-­‐1,	   MIC-­‐1,	   PDGF-­‐A,	   and	   FAS	   (Homo	   sapiens	   chromosomes	   19,	   7,	   and	   17,	  
respec?vely)	  were	   retrieved	   from	   the	   GRCh38	   Primary	   Assembly	   of	   the	   Gene	   database	  
available	   at	   the	   Na?onal	   Center	   for	   Biotechnology	   Informa?on	   (NCBI;	  
hlp://www.ncbi.nlm.nih.gov/).	  
EGR-­‐1	   regula:on	   of	   MIC-­‐1,	   PDGF-­‐A,	   and	   FAS	   was	   determined	   by	   quan?ta?ve	   reverse	  
transcriptase	   polymerase	   chain	   reac?on	   (qRT-­‐PCR)	   in	   non-­‐cancerous	   RWPE-­‐1	   human	  
prostate	  epithelial	  cells	   transfected	  with	  pcDNA3.1/EGR-­‐1	  plasmid.	  Data	  was	  normalized	  
to	  TATA	  binding	  protein.	  
Long-­‐term	  eﬀect	  of	  PIPER	  on	  EGR-­‐1	  expression	   in	  PC-­‐3	  human	  prostate	   cancer	   cells	  was	  
assessed	  by	  chemiluminescence	  Western	  blot	  analysis	  using	  an?bodies	  speciﬁc	  for	  	  EGR-­‐1	  
and	  β-­‐ac?n	  (for	  normaliza?on).	  	  
Hypothesized	  model	  for	  molecular	  prostate	  ﬁeld	  canceriza)on	  
Red	  arrows	  denote	  points	  covered	  	  in	  the	  present	  work	  
RESULTS	  
EGR-­‐1	  transcrip?on	  factor	  binding	  site	  analysis	  of	  genomic	  DNA	  sequences	  from	  -­‐1500bp	  to	  
+500bp	  rela?ve	  to	  the	  transcrip?on	  ini?a?on	  site	  of	  MIC-­‐1,	  PDGF-­‐A,	  and	  FAS.	  
CONCLUSIONS	  
•  Genomic	  sequences	  upstream	  of	  the	  transcrip?on	  ini?a?on	  sites	  of	  MIC-­‐1,	  
PDGF-­‐A,	  and	  FAS	  contain	  EGR-­‐1	  recogni?on	  sequences.	  	  
•  Ectopic	   expression	   of	   EGR-­‐1	   induces	  mRNA	   expression	   of	  MIC-­‐1,	   PDGF-­‐A,	  
and	  FAS	  elements	   factors.	  Transfec:on	  with	   the	  pcDNA3.1	  control	  plasmid	  
resulted	  in	  highly	  variable	  background	  expression.	  
•  While	  the	  telomerase	  inhibitor	  PIPER	  at	  sub-­‐lethal	  doses	  may	  induce	  EGR-­‐1	  
protein	   expression	   short-­‐term	   (5	   days),	   it	   does	   not	   do	   so	   long-­‐term	   (51	  
days).	  It	  remains	  to	  be	  shown	  whether	  telomere	  length	  was	  aﬀected	  during	  
this	  :me.	  
These	  preliminary	  results	  warrant	  further	  studies	  towards	  
tes?ng	   the	   hypothesized	   pathway	   of	   molecular	   ﬁeld	  
canceriza?on	  in	  prostate	  ?ssues.	  
Concept	   of	   the	   increased	   clinically	  
informa)ve	   area	   as	   it	   pertains	   to	  
prostate	   biopsies	   for	   conﬁrmatory	  





MIC-­‐1	   PDGF-­‐A	   FAS	  
pcDNA3.1	  control	   pcDNA3.1/EGR-­‐1	  
Eﬀect	   of	   ectopic	   expression	   of	  
EGR-­‐1	   on	   MIC-­‐1,	   PDGF-­‐A,	   and	   FAS	  
mRNA	   expression	   (y-­‐axis)	   in	  
RWPE-­‐1	   cells.	   Cells	   were	  
transfected	   for	   24	   hours.	  The	   ΔΔCt	  
method	   was	   and	   normaliza:on	   to	  
TATA	  binding	  protein	  were	  used.	  
Eﬀect	   of	   long-­‐term	   (51	   days)	  
exposure	  to	  1-­‐7.5µM	  PIPER	  on	  
EGR-­‐1	   protein	   expression	   in	  
PC-­‐3	   cells.	   Ra:ometric	  
densitometry	   was	   used	   to	  
determine	  expression.	  
